Case Study - Tackling Diabetic Kidney Disease Progression: Challenges, Advances, and Novel Approaches |
- 0.50 CDE
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
CMHC Masterclass On Demand: Connecting the Dots in Cardiometabolic Medicine - Integrative Approaches to Improve Patient Care |
- 14.00 CDE
- 14.00 ACPE Pharmacy
- 14.00 AMA PRA Category 1 Credit™
- 14.00 ANCC
- 14.00 Participation
|
Enduring |
|
$0.00 |
CMHC Spring 2022 On Demand |
- 16.25 CDE
- 16.25 ACPE Pharmacy
- 16.25 AMA PRA Category 1 Credit™
- 16.25 ANCC
- 16.25 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium: CGM - Going Beyond HbA1c to Optimize and Individualize T2D Management |
- 0.50 CDE
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium - Assessing the Role of TAVR Across the Risk Continuum: Emerging Evidence, Evolving Guidance, and Expert Perspectives |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Webcast: Challenging Cases in Patients with Iron Deficiency and Heart Failure |
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
Webcast: Advances in Screening, Diagnosis, and Treatment of Iron Deficiency in Heart Failure Patients |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: Should Diabetes Management be More Adipose-centric? |
- 0.50 CDE
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: The Disproportionate Burden of ATTR-CM In African Americans |
- 0.50 CDE
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
Digital Pathway: Challenges and Advances in the Diagnosis and Management of Immune Thrombocytopenic Purpura |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Digital Pathway - Changing The Treatment Paradigm for LDL-C Lowering Post-MI: The Case for Early, ‘High-Intensity Lipid Lowering Therapy’ to Improve... |
- 1.50 CDE
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 Participation
|
Enduring |
|
$0.00 |
Digital Pathway - Bridging the Frontiers of Care in Patients with T2D and CKD: Interpreting the Data with Novel MR Antagonists to Improve Cardiorenal... |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Digital Pathway - The Evolving Landscape of LDL-C Reduction in High Risk Patients: Optimizing Combination Therapy to Reduce ASCVD Risk |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium - Optimizing Lipid Lowering Therapy in Women: Gaps, Perspectives, and Advances |
- 0.75 ACPE Pharmacy
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation
|
Enduring |
|
$0.00 |
Webcast Series: Optimizing Long-Term Weight Loss in Patients with Type 2 Diabetes: Advances and Expert Perspectives |
|
Enduring |
|
$0.00 |